跳至主要内容
临床试验/NCT03228342
NCT03228342已完成不适用

The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)

Clínica de Artritis Temprana2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2017年5月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
94
试验地点
2
主要终点
Change from Baseline of the Patient Reported Outcome (HAQ)

研究概览

简要总结

Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A clinical diagnosis of RA made at the discretion of the attending experienced rheumatologist.
  • Patients classified in remission/low disease activity

排除标准

  • <16 years old.
  • Patient with recent trauma in the evaluated joints.
  • Luxation in the MCP, PIP or MTP joints.

研究组 & 干预措施

Ultrasound shared

Experimental

Patient will be assessed with ultrasound (GUS-7 score)

干预措施: MusculoSkeletal Ultrasound (Diagnostic Test)

Ultrasound not shared

Experimental

Patient will be assessed with ultrasound (GUS-7 score)

干预措施: MusculoSkeletal Ultrasound (Diagnostic Test)

结局指标

主要结局

Change from Baseline of the Patient Reported Outcome (HAQ)

时间窗: From baseline at 6 months

Minimal Clinically Significant change in HAQ

Change from Baseline of the Patient Reported Outcome (RADAI)

时间窗: from baseline at 6 months

Minimal Clinically Significant change in RADAI

Change from Baseline of the Patient Reported Outcome (SF-36)

时间窗: from baseline at 6 months

Minimal Clinically Significant change in SF-36

Change from Baseline of the Patient Reported Outcome (VAS-Patient)

时间窗: from baseline at 6 months

Minimal Clinically Significant change in VAS-Patient

次要结局

  • Ultrasound findings in Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity(Baseline)
  • Clinical relapse: Proportion of patients with relapse after the intervention in both groups(baseline and 6 months)
  • Change from Baseline of the Patient Reported Outcome (HAQ)(from baseline at 12 months)
  • Change from Baseline of the Patient Reported Outcome (RADAI)(from baseline at 12 months)
  • Change from Baseline of the Patient Reported Outcome (SF-36)(from baseline at 12 months)
  • Change from Baseline of the Patient Reported Outcome (VAS-Patient)(from baseline at 12 months)

研究者

发起方
Clínica de Artritis Temprana
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验